Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
mTOR-Activating Mutations in RRAGD Are Causative for Kidney Tubulopathy and Cardiomyopathy
Journal of the American Society of Nephrology
(
IF
13.6
)
Pub Date : 2021-11-01
, DOI:
10.1681/asn.2021030333
Karl P Schlingmann
1
,
François Jouret
2,
3
,
Kuang Shen
4,
5,
6,
7,
8
,
Anukrati Nigam
9
,
Francisco J Arjona
10
,
Claudia Dafinger
11,
12
,
Pascal Houillier
13,
14,
15
,
Deborah P Jones
16
,
Felix Kleinerüschkamp
17
,
Jun Oh
18
,
Nathalie Godefroid
19
,
Mehmet Eltan
20
,
Tülay Güran
20
,
Stéphane Burtey
21
,
Marie-Christine Parotte
22
,
Jens König
1
,
Alina Braun
11,
12
,
Caro Bos
10
,
Maria Ibars Serra
10
,
Holger Rehmann
23
,
Fried J T Zwartkruis
23
,
Kirsten Y Renkema
9
,
Karin Klingel
24
,
Eric Schulze-Bahr
25
,
Bernhard Schermer
12,
26
,
Carsten Bergmann
27,
28
,
Janine Altmüller
29
,
Holger Thiele
29
,
Bodo B Beck
30,
31,
32
,
Karin Dahan
33,
34
,
David Sabatini
4,
5,
6,
7
,
Max C Liebau
11,
12,
32
,
Rosa Vargas-Poussou
35
,
Nine V A M Knoers
36
,
Martin Konrad
1
,
Jeroen H F de Baaij
10
Affiliation
- Department of General Pediatrics, University Children's Hospital, Münster, Germany.
- Division of Nephrology, Department of Internal Medicine, University of Liège Hospital, Liège, Belgium.
- Interdisciplinary Group of Applied Genoproteomics, Cardiovascular Sciences, University of Liège, Liège, Belgium.
- Whitehead Institute for Biomedical Research, Cambridge, Massachusetts.
- Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts.
- Koch Institute for Integrative Cancer Research, Cambridge, Massachusetts.
- Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.
- Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
- Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Department of Physiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Pediatrics and Center for Molecular Medicine Cologne, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany.
- Department II of Internal Medicine and Center for Molecular Medicine Cologne, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany.
- Cordeliers Research Center, Centre National de la Recherche Scientifique (CNRS), ERL8228, Institut National de la Santé et de la Recherche Médicale (INSERM), Sorbonne University, University of Paris, Paris, France.
- Department of Physiology, Assistance Publique-Hôpitaux de Paris (AP-HP), European Hospital Georges Pompidou, Paris, France.
- Reference Center for Hereditary Renal Diseases in Children and Adults (MARHEA), Paris, France.
- Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
- Department of Pediatric Cardiology, University Children's Hospital, Münster, Germany.
- Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Division of Pediatric Nephrology, Saint-Luc University Clinics, Catholic University of Louvain, Brussels, Belgium.
- Department of Pediatric Endocrinology and Diabetes, School of Medicine, Marmara University, Istanbul, Turkey.
- Center for Nephrology and Renal Transplantation, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille University, Marseille, France.
- Division of Nephrology-Dialysis, Department of Internal Medicine, CHR Verviers East Belgium, Verviers, Belgium.
- Department of Molecular Cancer Research, Center for Molecular Medicine, Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands.
- Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.
- Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany.
- CECAD, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany.
- Limbach Genetics, Medizinische Genetik Mainz, Mainz, Germany.
- Division of Nephrology, Department of Medicine, University Hospital Freiburg, Breisgau, Germany.
- Cologne Center for Genomics, University of Cologne, Cologne, Germany.
- Institute of Human Genetics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany.
- Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
- Center for Rare Diseases, Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany.
- Center of Human Genetics, Gosselies, Belgium.
- Division of Nephrology, Saint-Luc University Clinics, Catholic University of Louvain, Brussels, Belgium.
- Department of Genetics, AP-HP, European Hospital Georges Pompidou, Paris, France.
- Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Background
Over the last decade, advances in genetic techniques have resulted in the identification of rare hereditary disorders of renal magnesium and salt handling. Nevertheless, approximately 20% of all patients with tubulopathy lack a genetic diagnosis.
Methods
We performed whole-exome and -genome sequencing of a patient cohort with a novel, inherited, salt-losing tubulopathy; hypomagnesemia; and dilated cardiomyopathy. We also conducted subsequent in vitro functional analyses of identified variants of RRAGD, a gene that encodes a small Rag guanosine triphosphatase (GTPase).
Results
In eight children from unrelated families with a tubulopathy characterized by hypomagnesemia, hypokalemia, salt wasting, and nephrocalcinosis, we identified heterozygous missense variants in RRAGD that mostly occurred de novo. Six of these patients also had dilated cardiomyopathy and three underwent heart transplantation. We identified a heterozygous variant in RRAGD that segregated with the phenotype in eight members of a large family with similar kidney manifestations. The GTPase RagD, encoded by RRAGD, plays a role in mediating amino acid signaling to the mechanistic target of rapamycin complex 1 (mTORC1). RagD expression along the mammalian nephron included the thick ascending limb and the distal convoluted tubule. The identified RRAGD variants were shown to induce a constitutive activation of mTOR signaling in vitro.
Conclusions
Our findings establish a novel disease, which we call autosomal dominant kidney hypomagnesemia (ADKH-RRAGD), that combines an electrolyte-losing tubulopathy and dilated cardiomyopathy. The condition is caused by variants in the RRAGD gene, which encodes Rag GTPase D; these variants lead to an activation of mTOR signaling, suggesting a critical role of Rag GTPase D for renal electrolyte handling and cardiac function.
中文翻译:
RRAGD 中的 mTOR 激活突变是肾小管病和心肌病的原因
背景
在过去的十年中,遗传技术的进步导致了罕见的肾镁和盐处理遗传性疾病的鉴定。然而,大约 20% 的肾小管病患者缺乏基因诊断。
方法
我们对患有新型遗传性失盐性肾小管病的患者队列进行了全外显子组和基因组测序;低镁血症; 和扩张型心肌病。我们还对已识别的RRAGD变体进行了后续的体外功能分析,RRAGD 是一种编码小型 Rag 鸟苷三磷酸酶 (GTPase) 的基因。
结果
在来自不相关家庭的 8 名患有以低镁血症、低钾血症、盐消耗和肾钙质沉着症为特征的肾小管病的儿童中,我们发现了RRAGD中的杂合错义变异,这些变异大多是从头发生的。这些患者中有 6 名还患有扩张型心肌病,3 名接受了心脏移植。我们在RRAGD中发现了一个杂合变体,该变体与具有相似肾脏表现的大家族的八个成员的表型分离。GTPase RagD,由RRAGD编码, 在介导氨基酸信号转导至雷帕霉素复合物 1 (mTORC1) 的机制靶点中发挥作用。沿哺乳动物肾单位的 RagD 表达包括粗升肢和远曲小管。已鉴定的RRAGD变体显示可在体外诱导 mTOR 信号传导的组成型激活。
结论
我们的研究结果确立了一种新的疾病,我们称之为常染色体显性遗传性肾低镁血症 (ADKH-RRAGD),它结合了电解质丢失性肾小管病和扩张型心肌病。这种情况是由RRAGD基因的变异引起的,该基因编码 Rag GTPase D;这些变体导致 mTOR 信号的激活,表明 Rag GTPase D 对肾电解质处理和心脏功能的关键作用。
更新日期:2021-10-30